Status:
COMPLETED
Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder
Lead Sponsor:
Showa University
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The purpose of this study is to predict and visualize sertraline treatment response in major depressive disorder with clinical symptoms, demographic and stress state, personality, eight genetic polymo...
Detailed Description
While only about 50% of patients respond to first treatment in major depressive disorder, 30-40% did not remit after continuous 1 year treatment. However, patients must remain on their prescribed medi...
Eligibility Criteria
Inclusion
- clinical diagnosis of Major Depressive Disorder
- Must be able to swallow tablets
Exclusion
- pregnant
- breastfeeding
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT01454635
Start Date
June 1 2008
End Date
March 1 2010
Last Update
October 31 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Showa University Northern Yokohama Hospital
Yokohama, Kanagawa, Japan, 224-8503